b-Tetrahydrocortisone Test

Cortisol is the stress hormone that wakes you up, fuels your reaction to a hard workout, and helps your body manage blood sugar. What most people do not realize is that your body is constantly switching cortisol off and on, converting it into an inactive partner molecule called cortisone, then back again. β-THE (β-tetrahydrocortisone) is one of the urinary leftovers from that switching process, and tracking it gives you a window into how well that on-off system is working.

A single blood cortisol value captures one moment in time. β-THE, measured in urine, reflects what your body actually did with cortisol over hours, and it appears in patterns linked to high blood pressure, insulin resistance, kidney disease, and adrenal disorders. This is a research-stage measurement without universal cutpoints, so its real value comes from tracking your own trend rather than chasing a number.

How Your Body Uses This Marker

Two enzymes called 11β-HSD1 and 11β-HSD2 (11-beta-hydroxysteroid dehydrogenases, the proteins that flip cortisol between its active and inactive forms) sit at the center of cortisol metabolism. Type 2 converts active cortisol into inactive cortisone in the kidney, protecting blood-pressure receptors from being overwhelmed. Type 1 does the reverse in the liver and fat tissue, regenerating active cortisol where it is needed.

After those switches happen, the liver further breaks down cortisone into tetrahydro-metabolites, including β-THE, which then leave the body in urine. By comparing β-THE to its sibling molecules (THF and 5α-THF, the matching breakdown products of cortisol), labs can estimate which of the two enzymes is dominant and how aggressively your body is clearing cortisol overall.

Why This Matters for Blood Pressure

When 11β-HSD2 is weak, active cortisol slips through and starts pulling on receptors that normally only respond to aldosterone, the hormone that drives sodium retention. The result is high blood pressure that does not respond well to standard treatments.

In a study of 14 children with apparent mineralocorticoid excess, a rare genetic version of this problem, the urinary ratio of cortisol metabolites to cortisone metabolites (the THF plus 5α-THF over THE ratio, an index that goes up when β-THE drops relative to its siblings) ran between 6.7 and 33, compared to roughly 1 in healthy controls. These children developed severe high blood pressure in childhood. In a separate analysis of adults with essential hypertension, a ratio above 1.5 was linked to reduced 11β-HSD2 activity and more hypertension-related heart damage.

What this means for you: if you have hard-to-control high blood pressure or low-renin hypertension, the pattern of β-THE relative to THF is one of the few markers that can suggest whether disrupted cortisol metabolism is part of the picture.

Obesity and Insulin Resistance

Cortisol metabolism shifts measurably with body weight. In a study comparing 72 severely obese adults to 30 lean controls, the obese participants had elevated 11β-HSD2 activity that tracked negatively with insulin sensitivity, meaning the people whose enzymes were working hardest to inactivate cortisol were also the ones whose cells were responding least well to insulin.

A separate study of 40 women found that obese women had increased reactivation of cortisol in fat tissue through 11β-HSD1, which is thought to contribute to the metabolic features of central obesity. In children, obesity was linked to broadly increased steroid metabolite excretion, particularly before puberty. In polycystic ovary syndrome, β-THE and other cortisone-metabolite excretion was elevated, with patterns suggesting enhanced 5α-reduction and reduced 11β-HSD1 activity.

What this means for you: if you carry visceral fat, have a diagnosis of insulin resistance, or have PCOS, your cortisol metabolism is likely altered in ways that contribute to the metabolic picture. β-THE and its ratios capture some of that biology that a fasting glucose or insulin test cannot.

Kidney and Liver Disease

Because the kidney is the main site of 11β-HSD2 activity and a major route for clearing steroid metabolites, kidney disease distorts β-THE in two ways at once. In a study of 97 patients on hemodialysis, plasma levels of THE, THF, and 5α-THF were markedly increased, and 11β-HSD2 activity was reduced. A review covering chronic kidney disease concluded that this cortisol excess likely contributes to higher mortality and worse cardiovascular outcomes in advanced kidney disease.

In cirrhosis, the pattern flips. A study of 21 patients with liver disease showed decreased THE proportions and increased cortolone isomers, reflecting reduced A-ring reduction of cortisone, which the liver normally performs. In critical illness more broadly, urinary ratios involving THE indicate reduced inactivation of cortisol in both liver and kidney, contributing to the high cortisol seen in ICU patients.

Adrenal Disorders

In Addison disease, where the adrenal glands cannot make enough cortisol, replacement therapy can over- or undershoot. In a randomized crossover trial of 50 patients with primary adrenal insufficiency (compared to 124 healthy controls), the once-daily dual-release hydrocortisone formulation normalized the urinary cortisol metabolome, including β-THE patterns, and improved metabolic markers compared to standard thrice-daily hydrocortisone.

In Cushing's syndrome at the opposite extreme, cortisol and tetrahydrocortisol metabolites climb, while β-THE often shifts in relative terms, reflecting impaired 11β-HSD2 activity. Urinary steroid metabotyping using these patterns can help distinguish Cushing subtypes.

Reference Ranges

β-THE is a research-stage measurement. No clinical guideline body publishes universal cutpoints, and the absolute number depends heavily on the assay and the laboratory. The most useful information comes from the ratios, particularly (THF + 5α-THF) / THE, which captures the balance between active and inactive cortisol breakdown.

These illustrative ratio ranges come from clinical case literature and observational studies in adults and children. They are oriented around the ratio that includes β-THE, not β-THE alone. Treat them as orientation, not as targets. Your lab will likely report different numbers, possibly in different units or as different specific ratios.

Compare your results within the same lab over time for the most meaningful trend. Different labs use different units, different reference intervals, and different ratio definitions, so direct number-to-number comparison across labs is unreliable.

Why One Reading Is Not Enough

Urinary steroid metabolites vary day to day with stress, sleep, hydration, recent illness, and the timing of cortisol's daily rhythm. A single β-THE result is a snapshot of one collection window, not a stable baseline. The patterns that matter clinically (sustained shifts in the ratios with kidney disease, sustained elevations with obesity-driven enzyme changes, sustained changes with adrenal replacement therapy) only emerge across multiple measurements.

The practical approach is to get a baseline, repeat in 3 to 6 months if you are making meaningful changes such as weight loss, blood pressure treatment, or adjustments to corticosteroid replacement, then at least annually if you are tracking how your cortisol metabolism is evolving. If a result is unexpected, retest before drawing conclusions.

What to Do With an Abnormal Result

Because β-THE is a research-stage marker, an out-of-range result is best read as a signal to investigate rather than a diagnosis on its own. The most useful next steps depend on the pattern:

• Elevated cortisol-to-cortisone ratio with high blood pressure: worth a workup for secondary causes of hypertension, including aldosterone, renin, and a referral to an endocrinologist or hypertension specialist if your blood pressure is hard to control.
• Elevated total cortisol metabolites including β-THE with metabolic symptoms: pair with fasting insulin, HbA1c, and a lipid panel to assess insulin resistance and consider further evaluation of cortisol status with morning serum cortisol and possibly low-dose dexamethasone testing.
• Abnormal pattern with known kidney or liver disease: the underlying organ disease is usually driving the changes, and managing that disease is the priority rather than treating the steroid pattern.
• Abnormal pattern on adrenal replacement therapy: discuss timing, formulation, and dose with the endocrinologist managing your replacement. A urinary steroid panel is one of the more sensitive ways to detect over- or under-replacement.

When Results Can Be Misleading

Several common situations can shift β-THE on a single test in ways that do not reflect your underlying biology:

• Acute illness or surgery: critical illness reduces hepatic and renal cortisol breakdown for days to weeks, producing patterns that look like adrenal disease but reflect the acute stress.
• Kidney function: reduced clearance concentrates plasma metabolites and alters urinary excretion. Stable kidney function is needed for the ratios to be interpretable.
• Cortisol-lowering medications: drugs like ketoconazole and metyrapone reduce urinary steroid metabolites as part of treating cortisol excess. Recent doses can distort patterns even though the change is intended.
• Collection timing and completeness: dried urine samples must be collected at the specified times of day. Missed timepoints or contamination can produce uninterpretable results.